Adjei A - Search Results

1

Potential applications for circulating tumor cells expressing the insulin-like growth factor-I receptor.

de Bono JS, Attard G, Adjei A, Pollak MN, Fong PC, Haluska P, Roberts L, Melvin C, Repollet M, Chianese D, Connely M, Terstappen LW, Gualberto A. de Bono JS, et al. Among authors: adjei a. Clin Cancer Res. 2007 Jun 15;13(12):3611-6. doi: 10.1158/1078-0432.CCR-07-0268. Clin Cancer Res. 2007. PMID: 17575225 Free article. Clinical Trial.

2

Novel pharmacological agents in clinical development for solid tumours.

Dy GK, Haluska P, Adjei AA. Dy GK, et al. Among authors: adjei aa. Expert Opin Investig Drugs. 2001 Dec;10(12):2059-88. doi: 10.1517/13543784.10.12.2059. Expert Opin Investig Drugs. 2001. PMID: 11772306 Review.

3

Receptor tyrosine kinase inhibitors.

Haluska P, Adjei AA. Haluska P, et al. Among authors: adjei aa. Curr Opin Investig Drugs. 2001 Feb;2(2):280-6. Curr Opin Investig Drugs. 2001. PMID: 11816845 Review.

4

Farnesyl transferase inhibitors as anticancer agents.

Haluska P, Dy GK, Adjei AA. Haluska P, et al. Among authors: adjei aa. Eur J Cancer. 2002 Sep;38(13):1685-700. doi: 10.1016/s0959-8049(02)00166-1. Eur J Cancer. 2002. PMID: 12175684 Review.

5

Phase I dose escalation study of the anti insulin-like growth factor-I receptor monoclonal antibody CP-751,871 in patients with refractory solid tumors.

Haluska P, Shaw HM, Batzel GN, Yin D, Molina JR, Molife LR, Yap TA, Roberts ML, Sharma A, Gualberto A, Adjei AA, de Bono JS. Haluska P, et al. Among authors: adjei aa. Clin Cancer Res. 2007 Oct 1;13(19):5834-40. doi: 10.1158/1078-0432.CCR-07-1118. Clin Cancer Res. 2007. PMID: 17908976 Clinical Trial.

6

Phase I trial of dolastatin-10 (NSC 376128) in patients with advanced solid tumors.

Pitot HC, McElroy EA Jr, Reid JM, Windebank AJ, Sloan JA, Erlichman C, Bagniewski PG, Walker DL, Rubin J, Goldberg RM, Adjei AA, Ames MM. Pitot HC, et al. Among authors: adjei aa. Clin Cancer Res. 1999 Mar;5(3):525-31. Clin Cancer Res. 1999. PMID: 10100703 Clinical Trial.

7

A Phase I study of bizelesin (NSC 615291) in patients with advanced solid tumors.

Pitot HC, Reid JM, Sloan JA, Ames MM, Adjei AA, Rubin J, Bagniewski PG, Atherton P, Rayson D, Goldberg RM, Erlichman C. Pitot HC, et al. Among authors: adjei aa. Clin Cancer Res. 2002 Mar;8(3):712-7. Clin Cancer Res. 2002. PMID: 11895900 Clinical Trial.

8

A phase I trial of ISIS 2503, an antisense inhibitor of H-ras, in combination with gemcitabine in patients with advanced cancer.

Adjei AA, Dy GK, Erlichman C, Reid JM, Sloan JA, Pitot HC, Alberts SR, Goldberg RM, Hanson LJ, Atherton PJ, Watanabe T, Geary RS, Holmlund J, Dorr FA. Adjei AA, et al. Clin Cancer Res. 2003 Jan;9(1):115-23. Clin Cancer Res. 2003. PMID: 12538459 Clinical Trial.

9

A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer.

Scott AM, Wiseman G, Welt S, Adjei A, Lee FT, Hopkins W, Divgi CR, Hanson LH, Mitchell P, Gansen DN, Larson SM, Ingle JN, Hoffman EW, Tanswell P, Ritter G, Cohen LS, Bette P, Arvay L, Amelsberg A, Vlock D, Rettig WJ, Old LJ. Scott AM, et al. Among authors: adjei a. Clin Cancer Res. 2003 May;9(5):1639-47. Clin Cancer Res. 2003. PMID: 12738716 Clinical Trial.

10

A Phase I trial of the farnesyl protein transferase inhibitor R115777 in combination with gemcitabine and cisplatin in patients with advanced cancer.

Adjei AA, Croghan GA, Erlichman C, Marks RS, Reid JM, Sloan JA, Pitot HC, Alberts SR, Goldberg RM, Hanson LJ, Bruzek LM, Atherton P, Thibault A, Palmer PA, Kaufmann SH. Adjei AA, et al. Clin Cancer Res. 2003 Jul;9(7):2520-6. Clin Cancer Res. 2003. PMID: 12855626 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

610 results

Search Page

Filters